In the wake of the COVID-19 pandemic, health systems in Tulsa continue to pursue expansion projects that will increase access to services and intensify competition within the provider sector. Health systems are targeting lucrative specialty care, such as oncology, as well as more cost-effective, convenient care, such as ambulatory surgery centers, for growth. These expansions could drive higher levels of medical utilization, including drug utilization. Physician groups are also deploying telehealth solutions such as virtual visits to maintain access to care and are beginning to distribute COVID-19 vaccines. In the payer sector, Blue Cross and Blue Shield of Oklahoma, Humana, UnitedHealthcare, and a subsidiary of Centene have won contracts for managing Oklahoma’s Medicaid program. As the state moves forward with managed Medicaid, it will also expand the program to an estimated 272,000 residents, which could improve the outlook for drug sales.


Related Reports

El Paso | Texas | 2021 | Market Overview Brief

The El Paso market was one of the worst hit by the COVID-19 pandemic as of fall 2020, with health systems straining tremendously to keep up as the number of cases skyrocketed. Under normal conditio...

View Details

Fresno | California | 2021 | Market Overview

The opening of a new medical school in 2020 is expected to help alleviate physician shortage issues over time. Fresno is plagued by pollution and poverty and its residents suffer from high rates of...

View Details

Greenville | South Carolina | 2021 | Market Overview

Although the COVID-19 pandemic remains top of mind, health systems in the Greenville market and BlueCross BlueShield of South Carolina are addressing the prevalence of cancer and diabetes in the ma...

View Details

Des Moines | Iowa | 2021 | Market Overview Brief

Several growth strategies and long-term plans for the Des Moines market’s influential health systems were disrupted in 2020 following the COVID-19 outbreak. UnityPoint Health and MercyOne, th...

View Details